2 Magnificent S&P 500 Dividend Stocks Down 7% and 19% to Buy and Hold Forever

American stocks were volatile this year, but they had a strong run. the S & P 500 The index gained 17.3 % during the past year until September 16.
However, just because the index has achieved well does not mean that you cannot find exceptions. coca cola (Nyse: ko) and Eli Lily (NYSE: LLY) More than 8 % and 14 % decreased, respectively.
This may make some investors be ashamed of shares. After all, the shares have reduced performance on the market for various reasons.
However, long -term investors interested in profit distributions should look at this as an excellent purchase opportunity.
Most people around the world heard about Coca -Cola. The company, which was launched in 1886, sells its drinks, including the brand of the same name, in more than 200 countries.
A mature company, the days of its revenue appear to be fossilized behind it. However, Coca-Cola has increased its upper line. The revenues of the second quarter, removal of foreign currency fluctuations and promotions, and acquisition/disposal, have grown by 5 %. This helped pay the 15 % modified operating income.
The revenue was fully due to the high prices and the variable product mixture, which contributed to 6 degrees Celsius. However, the decrease in the size of the latitude of 1 percentage. This may lead to the position of some investors, but consumers are likely to feel weary of constantly high inflation. At some point, prices will stop and sizes will increase. More importantly, the Coca -Cola market share in the non -alcoholic drink sector continued to expand.
Coca-Cola shareholders are based on stock profits, which are still an important source of the total shares. In fact, they expected a regular increase, and Coca-Cola raised the payment by more than 5 % in February. This company ran to 63 years in a row, making it the property of profits.
The stocks have a 3.1 % profit distribution return, more than twice the S&P 500 1.2 %. The payment rate of 71 % of Coca-Cola should provide the comfort that the company can easily bear.
Elie Lily, who was also present since the late nineteenth century, was very successful in developing and selling medications used to treat diabetes, cancer and immunity (rheumatoid arthritis), among other diseases.
It has three drugs, mounjaro, Zepbound, and Verzenio, which represents 65 % of the second -quarter revenue of $ 15.6 billion. These medications treat type 2 diabetes, obesity and breast cancer, respectively. Products have achieved growth above 12 % to 172 %, and continue to increase revenue growth.
Don’t miss more hot News like this! Click here to discover the latest in Business news!
2025-09-20 17:25:00